Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-017564

Chief Commercial Officer, MRD acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BOBULSKY SUSAN Chief Commercial Officer, MRD 2024-10-08 Option exercise +5,000 $1.98 $9,900 253,290 D
Derivatives
BOBULSKY SUSAN Chief Commercial Officer, MRD 2024-10-08 Option exercise · Stock Option (right to buy) −5,000 0 D
Loading xslF345X05/form4.xml…